Year |
Citation |
Score |
2020 |
Yu Y, Zu C, He D, Li Y, Chen Q, Chen Q, Wang H, Wang R, Chaurasiya B, Zaro JL, Wang Y, Tu J, Sun C. pH-dependent reversibly activatable cell-penetrating peptides improve the antitumor effect of artemisinin-loaded liposomes. Journal of Colloid and Interface Science. PMID 33189320 DOI: 10.1016/j.jcis.2020.10.103 |
0.779 |
|
2020 |
Liu Y, Wang HY, Shao J, Zaro JL, Shen WC. Enhanced insulin receptor interaction by a bifunctional insulin-transferrin fusion protein: an approach to overcome insulin resistance. Scientific Reports. 10: 7724. PMID 32382087 DOI: 10.1038/S41598-020-64731-9 |
0.625 |
|
2018 |
Tang B, Zaro JL, Shen Y, Chen Q, Yu Y, Sun P, Wang Y, Shen WC, Tu J, Sun C. Acid-sensitive hybrid polymeric micelles containing a reversibly activatable cell-penetrating peptide for tumor-specific cytoplasm targeting. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 29653223 DOI: 10.1016/J.Jconrel.2018.04.016 |
0.774 |
|
2018 |
Chen YS, Zaro JL, Zhang D, Huang N, Simon A, Shen WC. Characterization and Oral Delivery of Proinsulin-Transferrin Fusion Protein Expressed Using ExpressTec. International Journal of Molecular Sciences. 19. PMID 29373562 DOI: 10.3390/Ijms19020378 |
0.646 |
|
2017 |
Folchman-Wagner Z, Zaro J, Shen WC. Characterization of Polyelectrolyte Complex Formation Between Anionic and Cationic Poly(amino acids) and Their Potential Applications in pH-Dependent Drug Delivery. Molecules (Basel, Switzerland). 22. PMID 28665323 DOI: 10.3390/molecules22071089 |
0.644 |
|
2016 |
Zhou L, Wang HY, Tong S, Okamoto CT, Shen WC, Zaro JL. Single chain Fc-dimer-human growth hormone fusion protein for improved drug delivery. Biomaterials. 117: 24-31. PMID 27923197 DOI: 10.1016/J.Biomaterials.2016.11.051 |
0.664 |
|
2016 |
Shao J, Zaro JL, Shen WC. Tissue barriers and novel approaches to achieve hepatoselectivity of subcutaneously-injected insulin therapeutics. Tissue Barriers. 4: e1156804. PMID 27358753 DOI: 10.1080/21688370.2016.1156804 |
0.627 |
|
2016 |
Shao J, Zaro JL, Shen WC. Proinsulin-transferrin fusion protein exhibits a prolonged and selective effect on the control of hepatic glucose production in an experimental model of type 1 diabetes. Molecular Pharmaceutics. PMID 27280852 DOI: 10.1021/Acs.Molpharmaceut.6B00168 |
0.63 |
|
2015 |
Yeh TH, Chen YR, Chen SY, Shen WC, Ann DK, Zaro JL, Shen LJ. Selective intracellular delivery of recombinant arginine deiminase (ADI) using pH-sensitive cell penetrating peptides to overcome ADI resistance in hypoxic breast cancer cells. Molecular Pharmaceutics. PMID 26642391 DOI: 10.1021/Acs.Molpharmaceut.5B00706 |
0.753 |
|
2015 |
Zaro JL. Lipid-based drug carriers for prodrugs to enhance drug delivery. The Aaps Journal. 17: 83-92. PMID 25269430 DOI: 10.1208/S12248-014-9670-Z |
0.328 |
|
2015 |
Zaro JL, Shen WC. Cationic and amphipathic cell-penetrating peptides (CPPs): Their structures and in vivo studies in drug delivery Frontiers of Chemical Science and Engineering. DOI: 10.1007/S11705-015-1538-Y |
0.7 |
|
2014 |
Sun C, Shen WC, Tu J, Zaro JL. Interaction between cell-penetrating peptides and acid-sensitive anionic oligopeptides as a model for the design of targeted drug carriers. Molecular Pharmaceutics. 11: 1583-90. PMID 24697211 DOI: 10.1021/Mp400747K |
0.766 |
|
2014 |
Fei L, Yap LP, Conti PS, Shen WC, Zaro JL. Tumor targeting of a cell penetrating peptide by fusing with a pH-sensitive histidine-glutamate co-oligopeptide. Biomaterials. 35: 4082-7. PMID 24508076 DOI: 10.1016/J.Biomaterials.2014.01.047 |
0.748 |
|
2014 |
Wang Y, Shao J, Zaro JL, Shen WC. Proinsulin-transferrin fusion protein as a novel long-acting insulin analog for the inhibition of hepatic glucose production. Diabetes. 63: 1779-88. PMID 24353179 DOI: 10.2337/Db13-0973 |
0.638 |
|
2013 |
Chen X, Zaro JL, Shen WC. Fusion protein linkers: property, design and functionality. Advanced Drug Delivery Reviews. 65: 1357-69. PMID 23026637 DOI: 10.1016/J.Addr.2012.09.039 |
0.64 |
|
2013 |
Hackett MJ, Zaro JL, Shen WC, Guley PC, Cho MJ. Fatty acids as therapeutic auxiliaries for oral and parenteral formulations. Advanced Drug Delivery Reviews. 65: 1331-9. PMID 22921839 DOI: 10.1016/J.Addr.2012.07.012 |
0.662 |
|
2012 |
Zhang D, Lee HF, Pettit SC, Zaro JL, Huang N, Shen WC. Characterization of transferrin receptor-mediated endocytosis and cellular iron delivery of recombinant human serum transferrin from rice (Oryza sativa L.). Bmc Biotechnology. 12: 92. PMID 23194296 DOI: 10.1186/1472-6750-12-92 |
0.639 |
|
2012 |
Kenien R, Shen WC, Zaro JL. Vesicle-to-cytosol transport of disulfide-linked cargo mediated by an amphipathic cell-penetrating peptide. Journal of Drug Targeting. 20: 793-800. PMID 22994388 DOI: 10.3109/1061186X.2012.719899 |
0.741 |
|
2012 |
Chen X, Zaro JL, Shen WC. Pharmacokinetics of recombinant bifunctional fusion proteins. Expert Opinion On Drug Metabolism & Toxicology. 8: 581-95. PMID 22428984 DOI: 10.1517/17425255.2012.673585 |
0.64 |
|
2012 |
Zaro JL, Fei L, Shen WC. Recombinant peptide constructs for targeted cell penetrating peptide-mediated delivery. Journal of Controlled Release : Official Journal of the Controlled Release Society. 158: 357-61. PMID 22326404 DOI: 10.1016/J.Jconrel.2012.01.039 |
0.738 |
|
2012 |
Kenien R, Zaro JL, Shen WC. MAP-mediated nuclear delivery of a cargo protein. Journal of Drug Targeting. 20: 329-37. PMID 22225540 DOI: 10.3109/1061186X.2011.649481 |
0.745 |
|
2012 |
Mo RH, Zaro JL, Shen WC. Comparison of cationic and amphipathic cell penetrating peptides for siRNA delivery and efficacy. Molecular Pharmaceutics. 9: 299-309. PMID 22171592 DOI: 10.1021/Mp200481G |
0.793 |
|
2012 |
Mo RH, Zaro JL, Ou JH, Shen WC. Effects of Lipofectamine 2000/siRNA complexes on autophagy in hepatoma cells. Molecular Biotechnology. 51: 1-8. PMID 21660602 DOI: 10.1007/S12033-011-9422-6 |
0.76 |
|
2011 |
Wang Y, Chen YS, Zaro JL, Shen WC. Receptor-mediated activation of a proinsulin-transferrin fusion protein in hepatoma cells. Journal of Controlled Release : Official Journal of the Controlled Release Society. 155: 386-92. PMID 21756950 DOI: 10.1016/J.Jconrel.2011.06.029 |
0.676 |
|
2011 |
Chen X, Lee HF, Zaro JL, Shen WC. Effects of receptor binding on plasma half-life of bifunctional transferrin fusion proteins. Molecular Pharmaceutics. 8: 457-65. PMID 21291258 DOI: 10.1021/Mp1003064 |
0.628 |
|
2011 |
Fei L, Ren L, Zaro JL, Shen WC. The influence of net charge and charge distribution on cellular uptake and cytosolic localization of arginine-rich peptides. Journal of Drug Targeting. 19: 675-80. PMID 21142649 DOI: 10.3109/1061186X.2010.531729 |
0.687 |
|
2010 |
Chen X, Bai Y, Zaro JL, Shen WC. Design of an in vivo cleavable disulfide linker in recombinant fusion proteins. Biotechniques. 49: 513-8. PMID 20615204 DOI: 10.2144/000113450 |
0.628 |
|
2009 |
Zaro JL, Vekich JE, Tran T, Shen WC. Nuclear localization of cell-penetrating peptides is dependent on endocytosis rather than cytosolic delivery in CHO cells. Molecular Pharmaceutics. 6: 337-44. PMID 19718791 DOI: 10.1021/Mp800239P |
0.723 |
|
2007 |
Patel LN, Zaro JL, Shen WC. Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives. Pharmaceutical Research. 24: 1977-92. PMID 17443399 DOI: 10.1007/S11095-007-9303-7 |
0.706 |
|
2006 |
Zaro JL, Rajapaksa TE, Okamoto CT, Shen WC. Membrane transduction of oligoarginine in HeLa cells is not mediated by macropinocytosis. Molecular Pharmaceutics. 3: 181-6. PMID 16579647 DOI: 10.1021/Mp0500869 |
0.704 |
|
2005 |
Zaro JL, Shen WC. Cytosolic delivery of a p16-peptide oligoarginine conjugate for inhibiting proliferation of MCF7 cells. Journal of Controlled Release : Official Journal of the Controlled Release Society. 108: 409-17. PMID 16202470 DOI: 10.1016/J.Jconrel.2005.08.028 |
0.687 |
|
2005 |
Zaro JL, Shen WC. Evidence that membrane transduction of oligoarginine does not require vesicle formation. Experimental Cell Research. 307: 164-73. PMID 15922736 DOI: 10.1016/J.Yexcr.2005.02.024 |
0.635 |
|
2003 |
Zaro JL, Shen WC. Quantitative comparison of membrane transduction and endocytosis of oligopeptides. Biochemical and Biophysical Research Communications. 307: 241-7. PMID 12859946 DOI: 10.1016/S0006-291X(03)01167-7 |
0.65 |
|
Show low-probability matches. |